ARID4B and prostate cancer: Analysis of five prostate cancer genome datasets using the cBioportal data source (http://www.cbioportal.org/) suggest that ARID4B and PTEN deletions tend to be mutually exclusive in the prostate cancer genome, although the relationship did not reach statistical significance (P > 0.05) (Supplementary Table 3).